Alexandre André Balieiro Costa

16PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 15, 2024
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer.

Ramya Ravindranathan, Ozge Somuncu, Alexandre André B A da Costa

|Jun 17, 2024
Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor Sensitivity.

Alexandre A da Costa, Ozge Somuncu, Ramya Ravindranathan

|Apr 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.

Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee

|Feb 02, 2023
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma.

Rafael Leite Nunes, Flávio Rodrigues Teixeira, Thiago Pereira Diniz

|Dec 11, 2022
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma.

Anna Paula Carreta Ruano, Andrea Paiva Gadelha Guimarães, Alexcia C Braun

|Oct 06, 2022
Targeting replication stress in cancer therapy.

Alexandre André B A da Costa, Dipanjan Chowdhury, Geoffrey I Shapiro

Pageof 3

Frequent Collaborators

5 joint publications

Alan D D'Andrea

4 joint publications

Geoffrey I Shapiro

3 joint publications

Panagiotis A Konstantinopoulos

2 joint publications

Madeline Polak